The reverse tetracycline-controlled transactivator rtTA2S-S2 is toxic in mouse embryonic stem cells

Reproduction Nutrition Development

Volumn 43, Issue 6, 2003, Pages 477-486

  Bryja, Vitezslav ^a,b   Pachernik, Jiri ^a,c   Kubala, Lukas ^d   Hampl, Ales ^a,b,c   Dvorak, Petr ^a,b,c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^c MENDEL UNIVERSITY IN BRNO   (Czech Republic)

^d INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

Embryonic stem cell; Reverse tetracycline controlled transactivator; TetOn system; Toxicity

Indexed keywords

ANTIBIOTIC G 418; NEOMYCIN; PHOSPHOTRANSFERASE; TETRACYCLINE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; EMBRYO CELL; GENE EXPRESSION; GENE SEQUENCE; GENETIC STABILITY; MOUSE; NONHUMAN; STEM CELL; TOXICITY TESTING; TRANSACTIVATION; VIRUS GENE;

ANIMALS; BETA-GALACTOSIDASE; CELL DIVISION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC VECTORS; HUMANS; LUCIFERASES; MICE; PLASMIDS; STEM CELLS; TETRACYCLINE; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSFECTION;

EID: 1842862671     PISSN: 09265287     EISSN: None     Source Type: Journal    
DOI: 10.1051/rnd:2004001     Document Type: Article

References (20)

1. Rathjen PD, Lake J, Whyatt LM, Bettess MD, Rathjen J. Properties and uses of embryonic stem cells: Prospects for application to human biology and gene therapy. Reprod Fertil Dev 1998, 10: 31-47.
2. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promotors. Proc Natl Acad Sci USA 1992, 89: 5547-5551.
3. Gossen M, Freundlieb S, Bender G, Müller G, Hillen W, Bujard H. Trancriptional activation by tetracyclines in mammalian cells. Science 1995, 268: 1766-1769.
4. Moutier R, Tchang F, Caucheteux SM, Kanellopoulos-Langevin C. Placental anomalies and fetal loss in mice, after administration of doxycycline in food for tet-system activation. Transgenic Res 2003, 12: 369-373.
5. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W. Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 2000, 97: 7963-7968.
6. Ibanez CE, Lipsick JS. Trans activation of gene expression by v-myb. Mol Cell Biol 1990, 10: 2285-2293.
7. Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morph 1995, 87: 27-45.
8. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press, New York, 1989.
9. Kipl-deficient mice. Cell 1996, 85: 733-744.
10. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000, 24: 372-376.
11. Era T, Witte ON. Regulated expression of P210 Bcr-Abl during embryonic stem cell differentiation stimulate multipotential progenitor expansion and myeloid cell fate. Proc Natl Acad Sci USA 2000, 97: 1737-1742.
12. Elder D, Robins A. Control of transgenesis in higher cells: The procell transposon Tn10 TetR mRNA has several major hairpins and can be unstable in eucells. Riv Biol - Biol Forum 1999, 92: 275-282.
13. Valencik ML, McDonald JA. Codon optimization markedly improves doxycycline regulated gene expression in the mouse heart. Transgenic Res 2001, 10: 269-275.
14. Wells KD, Foster JA, Moore K, Pursel VG, Wall RJ. Codon optimization, genetic insulation, and an rtTA reporter improve performance of the tetracycline switch. Transgenic Res 1999, 8: 371-381.
15. Gopalkrishnan RV, Christiansen KA, Goldstein NI, DePinho RA, Fisher PB. Use of the human EF-1a promotor for expression can significantly increase success in establishing stable cell lines with consistent expression: A study using the tetracycline-inducible system in human cancer cells. Nucleic Acids Res 1999, 27: 4775-4782.
16. Gallia GL, Khalili K. Evaluation of an autoregulatory tetracycline regulated system. Oncogene 1998, 16: 1879-1884.
17. Baron U, Gossen M, Bujard H. Tetracycline-controlled transcription in eukaryotes: Novel transactivators with graded transactivation potential. Nucleic Acids Res 1997, 25: 2723-2729.
18. Fedorov LM, Tyrsin OY, Krenn V, Chernigovskaya EV, Rapp UR. Tet-system for the regulation of gene expression during embryonic development. Transgenic Res 2001, 10: 247-258.
19. Furth PA, St Onge L, Böger H, Gruss P, Gossen M, Kistner A, Bujard H, Hennighausen L. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promotor. Proc Natl Acad Sci USA 1994, 91: 9302-9306.
20. Corbel SY, Rossi FMV. Latest developments and in vivo use of the Tet system: Ex vivo and in vivo delivery of tetracycline-regulated genes. Curr Opin Biotechnol 2002, 13: 448-452.